| （単位：千ドル） | 1Q22 | 2Q22 | 3Q22 | 1Q23 | 2Q23 | 3Q23 | 1Q24 | 2Q24 | 3Q24 | 1Q25 |
|---|---|---|---|---|---|---|---|---|---|---|
| 研究開発費 | 15,362 | 15,920 | 13,977 | 19,035 | 19,818 | 21,526 | 24,901 | 29,069 | 32,928 | 30,880 |
| 営業費用 | 25,420 | 27,256 | 25,536 | 31,788 | 32,664 | 34,062 | 38,573 | 43,322 | 47,896 | 49,616 |
| 営業利益 | -25,420 | -27,256 | -25,536 | -31,788 | -32,664 | -34,062 | -38,573 | -43,322 | -47,896 | -49,616 |
| 経常（税引前）利益 | -21,031 | -20,981 | -18,251 | -24,078 | -28,141 | -33,327 | -34,965 | -37,925 | -38,329 | -17,510 |
| 法人税等合計 | 140 | 56 | 120 | 130 | 194 | 62 | 222 | 176 | 173 | 354 |
| 実効税率（％） | ||||||||||
| 純利益 | -21,200 | -21,037 | -18,371 | -24,200 | -28,335 | -33,389 | -35,187 | -38,101 | -38,502 | -17,864 |
| 一株あたり利益 | -0.5 | -0.5 | -0.43 | -0.57 | -0.62 | -0.67 | -0.55 | -560 | -0.56 | -0.2 |
| 希薄化後一株あたり利益 | -0.5 | -0.5 | -0.43 | -0.57 | -0.62 | -0.67 | -0.55 | -560 | -0.56 | -0.24 |
| EBITDA | - | - | - | - | - |